Literature DB >> 7649150

Mechanisms of nuclear signalling by vitamin D3. Interplay with retinoid and thyroid hormone signalling.

C Carlberg1.   

Abstract

Hormones that act through nuclear receptors contribute to vertebrate development and homeostasis by serving as biological signals to control cellular growth and differentiation. Their response pathways must meet two requirements, which can be contradictory: they must be highly specific for a given signal, but at the same time they have to be flexible, allowing different responses under different physiological conditions. The current model for nuclear signalling of vitamin D3 (calcitriol), thyroid hormone and retinoic acid seems to be too simple to solve the specificity puzzle. Therefore, an advanced model is proposed that combines recent findings on the structure of hormone response elements, the promiscuous dimerization of the receptors for vitamin D3, thyroid hormone and retinoids and the heterodimer polarity. Special attention is taken on the mechanism of vitamin D3 signalling, where at least 14 different pathways are differentiated.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7649150

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  23 in total

1.  Large-scale expression and purification of the human vitamin D receptor and its ligand-binding domain for structural studies.

Authors:  K Juntunen; N Rochel; D Moras; P Vihko
Journal:  Biochem J       Date:  1999-12-01       Impact factor: 3.857

2.  Vitamin D receptor expression in colorectal cancer.

Authors:  M G Thomas; P A Sylvester; P Newcomb; R J Longman
Journal:  J Clin Pathol       Date:  1999-03       Impact factor: 3.411

3.  1,25-dihydroxyvitamin D3 and its nuclear receptor repress human α1 (I) collagen expression and type I collagen formation.

Authors:  James J Potter; Xiaopu Liu; Ayman Koteish; Esteban Mezey
Journal:  Liver Int       Date:  2013-02-17       Impact factor: 5.828

4.  Single thyroid hormone receptor monomers are competent for co-activator-mediated transactivation.

Authors:  M Quack; C Carlberg
Journal:  Biochem J       Date:  2001-12-01       Impact factor: 3.857

Review 5.  Regulation of cytochrome P450 (CYP) genes by nuclear receptors.

Authors:  P Honkakoski; M Negishi
Journal:  Biochem J       Date:  2000-04-15       Impact factor: 3.857

6.  Enhanced CD103 Expression and Reduced Frequencies of Virus-Specific CD8+ T Cells Among Airway Lymphocytes After Influenza Vaccination of Mice Deficient in Vitamins A + D.

Authors:  Sherri L Surman; Bart G Jones; David L Woodland; Julia L Hurwitz
Journal:  Viral Immunol       Date:  2017-11-13       Impact factor: 2.257

Review 7.  Differential Regulation of CYP3A4 and CYP3A5 and its Implication in Drug Discovery.

Authors:  Ogheneochukome Lolodi; Yue-Ming Wang; William C Wright; Taosheng Chen
Journal:  Curr Drug Metab       Date:  2017       Impact factor: 3.731

Review 8.  Using components of the vitamin D pathway to prevent and treat colon cancer.

Authors:  Renee E Stubbins; Aisha Hakeem; Nomelí P Núñez
Journal:  Nutr Rev       Date:  2012-10-12       Impact factor: 7.110

9.  Involvement of SMRT corepressor in transcriptional repression by the vitamin D receptor.

Authors:  Ji Young Kim; You Lee Son; Young Chul Lee
Journal:  Mol Endocrinol       Date:  2008-12-19

Review 10.  The yin and yang of vitamin D receptor (VDR) signaling in neoplastic progression: operational networks and tissue-specific growth control.

Authors:  F C Campbell; Haibo Xu; M El-Tanani; P Crowe; V Bingham
Journal:  Biochem Pharmacol       Date:  2009-09-06       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.